Merrill Head of Mkt Making 1986-2003.Large stakes:Spsy(17p),)Kino(11p),RGG(12p)Apta0.2p,Ken 2.6p, $Wrby$22)DSG(8p),DYOR 5 time Chandos tennis champ GB waterpolo
London, England
Joined September 2009
- Tweets18.2K
- Following1.8K
- Followers5.6K
- Likes28K
We maybe 6 to 9 months from a market top in a massively overvalued market but I’m still finding multi-baggers.
Watch what directors do NOT what they say!!
All CEO’s think their co is worth 10x !
#FEVR might be as directors are buying !!
Fever-Tree, announces that on 20 Oct 2026, David Lapp, a Non-Executive Director, purchased 23,800 shares in the Company at an average price of £9.355.
Im long #VRCI at 0.2p
Hoping for a 1 to 2 bagger.
#VRCI (£9.1m mrkcap)
After successfully raising £8.75m (gross) earlier this month at 0.2p/share, kidney-transplant diagnostics expert @VericiDx announced some further positive news today.
Saying that it had signed an order (value not disclosed) with the healthcare/therapeutics division of Asahi Kasei Group ($13.5bn mrkcap) wrt an upcoming Phase 2 clinical trial evaluating pegrizeprument. An investigational maintenance immunosuppressive therapy being developed for the prevention of acute rejection in solid organ transplant patients.
Moreover as part of the trial, Verici Dx will perform blood-based biomarker testing, including using its Pre-Transplant Risk Assessment (PTRA) assay, which is also being separately commercialised by Thermo Fisher. The molecular data generated will help evaluate biomarker signatures associated with receiving pegrizeprument.
CEO Sara Barrington, commenting: "Clinical trials represent an important opportunity to better understand the biological mechanisms underlying transplant success and rejection. By incorporating advanced molecular diagnostics into therapeutic development and clinical research, we can generate valuable insights that may ultimately help personalize post-transplant care.”
But that’s not all
Elsewhere @VericiDx said that it welcomed the US Department of Health & Human Services' launch of the 2026 Kidney Care National Plan. A strategy focused on preventing kidney failure, improving dialysis care and reforming transplantation. Clearly a move which should hopefully boost sales of its lead diagnostic Tutivia, which assesses acute rejection risk in kidney transplant patients - crucially before possible damage to a transplanted organ has occurred.
Disclosure: @VericiDx is a @VOXmarkets client.
Petit always a legend.
Europe doomed cos of the Far Left and pro pal/hamas supporters. Shame on them.
Arsenal legend Emmanuel Petit slams French rioters - 'Go back from where you came'
gbnews.com/sport/football/ar…
#APTA
Show me any other AIM co where there is a placing at 0.6p yet directors pay 0.1p !! Its UNETHICAL,IMMORAL and damn right WRONG.
Far left will bring Totalitarianism by 2035.
Timestamp this tweet.
Thats what I’m predicting.
Read the room @UKLabour
Still should double #PCiP
Have a great weekend all.
Been a gruntling week.
Won a prestigious global padel tmnt and my share portfolio done well.
Just need a rally in the silver price 🩷
